IDEAS home Printed from https://ideas.repec.org/h/spr/sprchp/978-3-319-18539-2_22.html

Regulatory Issues

In: Fundamentals of Clinical Trials

Author

Listed:
  • Lawrence M. Friedman

  • Curt D. Furberg

    (Wake Forest School of Medicine)

  • David L. DeMets

    (University of Wisconsin, Department of Biostatistics)

  • David M. Reboussin

    (Wake Forest School of Medicine, Department of Biostatistics)

  • Christopher B. Granger

    (Duke University, Department of Medicine)

Abstract

The purpose of a clinical trial is to assess reliably the benefits and harms of an intervention. In this book, we have focused on good clinical trial design, conduct, monitoring, and analysis principles. For many clinical trials, including those involving new drugs, devices, or biologics, or new indications for existing interventions, there are national and local regulations that must be followed in order to conduct clinical research, including the types of trials we have discussed. Furthermore, in order for an industry sponsor to market a medical product, regulatory agency approval is required in the U.S. and much of the rest of the world. The primary goal of this chapter is not to summarize all of the regulations relating to medical products; that is beyond the scope of this book. Rather, it is to focus on those laws, regulations and policies that bear on the design, conduct, and reporting of clinical trials. Even then, it will be highly selective, limited to those aspects that we think are most relevant and we will concentrate on U.S. laws, policies and regulations.

Suggested Citation

  • Lawrence M. Friedman & Curt D. Furberg & David L. DeMets & David M. Reboussin & Christopher B. Granger, 2015. "Regulatory Issues," Springer Books, in: Fundamentals of Clinical Trials, edition 0, chapter 0, pages 519-542, Springer.
  • Handle: RePEc:spr:sprchp:978-3-319-18539-2_22
    DOI: 10.1007/978-3-319-18539-2_22
    as

    Download full text from publisher

    To our knowledge, this item is not available for download. To find whether it is available, there are three options:
    1. Check below whether another version of this item is available online.
    2. Check on the provider's web page whether it is in fact available.
    3. Perform a
    for a similarly titled item that would be available.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:sprchp:978-3-319-18539-2_22. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.